| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncogene Proteins, Fusion | 14 | 2025 | 208 | 1.740 |
Why?
|
| Ribonuclease III | 4 | 2025 | 89 | 1.230 |
Why?
|
| DEAD-box RNA Helicases | 4 | 2025 | 121 | 1.030 |
Why?
|
| Neoplasms | 10 | 2024 | 2765 | 1.000 |
Why?
|
| Repressor Proteins | 8 | 2025 | 816 | 0.990 |
Why?
|
| Sarcoma | 7 | 2024 | 183 | 0.960 |
Why?
|
| Kidney Neoplasms | 5 | 2025 | 431 | 0.900 |
Why?
|
| Germ-Line Mutation | 7 | 2025 | 332 | 0.870 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 417 | 0.820 |
Why?
|
| Microtubule Proteins | 3 | 2009 | 27 | 0.810 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2024 | 545 | 0.810 |
Why?
|
| Receptor, trkA | 1 | 2022 | 15 | 0.780 |
Why?
|
| Mutation | 20 | 2024 | 5817 | 0.770 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 16 | 0.770 |
Why?
|
| Spermatozoa | 7 | 2009 | 224 | 0.750 |
Why?
|
| Soft Tissue Neoplasms | 5 | 2022 | 121 | 0.720 |
Why?
|
| DNA Copy Number Variations | 4 | 2022 | 948 | 0.720 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2024 | 869 | 0.710 |
Why?
|
| Brain Neoplasms | 5 | 2024 | 1210 | 0.700 |
Why?
|
| Biomarkers, Tumor | 12 | 2023 | 1475 | 0.680 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2022 | 72 | 0.670 |
Why?
|
| Sarcoma, Clear Cell | 2 | 2019 | 20 | 0.670 |
Why?
|
| DNA Polymerase II | 1 | 2019 | 19 | 0.660 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 29 | 0.660 |
Why?
|
| Gene Fusion | 5 | 2024 | 55 | 0.590 |
Why?
|
| Reproduction | 2 | 2011 | 239 | 0.530 |
Why?
|
| Medulloblastoma | 1 | 2019 | 335 | 0.510 |
Why?
|
| Vulvar Neoplasms | 1 | 2016 | 18 | 0.510 |
Why?
|
| Dermatofibrosarcoma | 1 | 2016 | 17 | 0.510 |
Why?
|
| Cytoskeletal Proteins | 3 | 2022 | 268 | 0.490 |
Why?
|
| Liver Neoplasms | 5 | 2022 | 1309 | 0.490 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 564 | 0.470 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2023 | 1135 | 0.460 |
Why?
|
| Translocation, Genetic | 3 | 2025 | 355 | 0.460 |
Why?
|
| Laboratory Proficiency Testing | 2 | 2024 | 8 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2025 | 59 | 0.450 |
Why?
|
| Germ Cells | 3 | 2024 | 194 | 0.450 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2014 | 24 | 0.440 |
Why?
|
| Infertility, Male | 6 | 2011 | 263 | 0.440 |
Why?
|
| Humans | 67 | 2025 | 124175 | 0.420 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2025 | 541 | 0.420 |
Why?
|
| Hepatoblastoma | 3 | 2022 | 179 | 0.410 |
Why?
|
| Child | 31 | 2025 | 24356 | 0.410 |
Why?
|
| Thyroid Neoplasms | 3 | 2021 | 190 | 0.410 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2022 | 931 | 0.380 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 2 | 2022 | 20 | 0.380 |
Why?
|
| Sperm Head | 2 | 2011 | 9 | 0.360 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2815 | 0.360 |
Why?
|
| Genitalia, Female | 1 | 2011 | 47 | 0.360 |
Why?
|
| Sequence Analysis, RNA | 4 | 2024 | 372 | 0.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 1891 | 0.330 |
Why?
|
| Rhabdomyosarcoma | 2 | 2023 | 191 | 0.320 |
Why?
|
| Metabolic Diseases | 1 | 2010 | 129 | 0.320 |
Why?
|
| Pyrazoles | 2 | 2021 | 306 | 0.310 |
Why?
|
| Female | 35 | 2025 | 66275 | 0.310 |
Why?
|
| Sperm Motility | 1 | 2009 | 94 | 0.310 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 809 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2025 | 3151 | 0.300 |
Why?
|
| Pyrimidines | 2 | 2021 | 370 | 0.300 |
Why?
|
| Male | 37 | 2025 | 60998 | 0.300 |
Why?
|
| Cyclin B | 2 | 2019 | 22 | 0.280 |
Why?
|
| Sequence Analysis, DNA | 3 | 2022 | 1748 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 1282 | 0.280 |
Why?
|
| Asthenozoospermia | 1 | 2007 | 6 | 0.280 |
Why?
|
| Child, Preschool | 14 | 2025 | 13997 | 0.270 |
Why?
|
| Gonads | 1 | 2007 | 35 | 0.270 |
Why?
|
| Fertility | 1 | 2009 | 257 | 0.270 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2017 | 167 | 0.270 |
Why?
|
| Sarcoma, Ewing | 2 | 2018 | 106 | 0.270 |
Why?
|
| Cell Shape | 1 | 2006 | 61 | 0.270 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 145 | 0.270 |
Why?
|
| Protein C Deficiency | 1 | 2006 | 12 | 0.260 |
Why?
|
| Immunohistochemistry | 5 | 2017 | 1689 | 0.260 |
Why?
|
| Protein C | 1 | 2006 | 21 | 0.260 |
Why?
|
| Adolescent | 20 | 2025 | 19243 | 0.260 |
Why?
|
| Carcinoma | 2 | 2021 | 284 | 0.260 |
Why?
|
| Thrombophilia | 1 | 2006 | 43 | 0.250 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 217 | 0.250 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2018 | 154 | 0.250 |
Why?
|
| Pineal Gland | 1 | 2025 | 18 | 0.240 |
Why?
|
| Pinealoma | 1 | 2025 | 19 | 0.240 |
Why?
|
| Infant | 15 | 2025 | 12465 | 0.240 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2025 | 22 | 0.240 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 314 | 0.240 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2025 | 39 | 0.230 |
Why?
|
| Mammals | 1 | 2006 | 256 | 0.230 |
Why?
|
| DNA Mutational Analysis | 4 | 2020 | 793 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 457 | 0.220 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 668 | 0.220 |
Why?
|
| Models, Animal | 1 | 2006 | 459 | 0.220 |
Why?
|
| Wilms Tumor | 1 | 2025 | 112 | 0.220 |
Why?
|
| Brain Abscess | 1 | 2024 | 56 | 0.220 |
Why?
|
| Histiocytosis, Langerhans-Cell | 2 | 2017 | 224 | 0.220 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2024 | 152 | 0.220 |
Why?
|
| Gangliosides | 1 | 2024 | 69 | 0.220 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 128 | 0.210 |
Why?
|
| DNA Mismatch Repair | 2 | 2022 | 49 | 0.210 |
Why?
|
| Meningioma | 1 | 2025 | 120 | 0.210 |
Why?
|
| Granulosa Cell Tumor | 2 | 2020 | 40 | 0.210 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2021 | 87 | 0.210 |
Why?
|
| Genetic Testing | 4 | 2024 | 997 | 0.210 |
Why?
|
| Meningeal Neoplasms | 1 | 2025 | 186 | 0.210 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 35 | 0.210 |
Why?
|
| Neutropenia | 1 | 2024 | 200 | 0.200 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 70 | 0.190 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 61 | 0.190 |
Why?
|
| Testis | 1 | 2004 | 409 | 0.190 |
Why?
|
| Maintenance Chemotherapy | 1 | 2021 | 20 | 0.190 |
Why?
|
| Mammary Analogue Secretory Carcinoma | 1 | 2021 | 8 | 0.190 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2024 | 196 | 0.190 |
Why?
|
| MyoD Protein | 1 | 2021 | 21 | 0.190 |
Why?
|
| Anticoagulants | 1 | 2006 | 588 | 0.180 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2021 | 55 | 0.180 |
Why?
|
| Mice, Knockout | 6 | 2009 | 3725 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2025 | 2583 | 0.180 |
Why?
|
| PAX7 Transcription Factor | 2 | 2018 | 17 | 0.180 |
Why?
|
| RNA-Binding Protein EWS | 2 | 2018 | 33 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2025 | 799 | 0.180 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 10 | 0.180 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2020 | 5 | 0.180 |
Why?
|
| Astrocytoma | 1 | 2021 | 100 | 0.180 |
Why?
|
| Ovary | 2 | 2020 | 379 | 0.170 |
Why?
|
| Clonal Evolution | 1 | 2020 | 39 | 0.170 |
Why?
|
| Mediastinal Neoplasms | 1 | 2020 | 40 | 0.170 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 2046 | 0.170 |
Why?
|
| Ependymoma | 1 | 2021 | 125 | 0.170 |
Why?
|
| Carcinoma, Papillary | 1 | 2020 | 70 | 0.170 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 18 | 0.170 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 12 | 0.170 |
Why?
|
| Myofibromatosis | 1 | 2019 | 8 | 0.170 |
Why?
|
| Imatinib Mesylate | 1 | 2019 | 44 | 0.170 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 301 | 0.160 |
Why?
|
| Egg Proteins | 2 | 2011 | 55 | 0.160 |
Why?
|
| Young Adult | 10 | 2024 | 8990 | 0.160 |
Why?
|
| Mice | 11 | 2022 | 17618 | 0.160 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 14 | 0.160 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 9 | 0.160 |
Why?
|
| Adult | 11 | 2025 | 29339 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 157 | 0.160 |
Why?
|
| Testicular Neoplasms | 1 | 2020 | 132 | 0.160 |
Why?
|
| Azacitidine | 1 | 2019 | 53 | 0.160 |
Why?
|
| Carcinogenesis | 1 | 2022 | 332 | 0.160 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2019 | 51 | 0.150 |
Why?
|
| Oncogene Fusion | 2 | 2017 | 22 | 0.150 |
Why?
|
| Carcinoma, Small Cell | 1 | 2018 | 51 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 882 | 0.150 |
Why?
|
| Flagella | 2 | 2009 | 28 | 0.150 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 2521 | 0.150 |
Why?
|
| Drug Therapy | 1 | 2018 | 87 | 0.140 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 183 | 0.140 |
Why?
|
| Myofibroma | 1 | 2017 | 9 | 0.140 |
Why?
|
| Prognosis | 5 | 2021 | 4609 | 0.140 |
Why?
|
| Genomics | 4 | 2021 | 1491 | 0.140 |
Why?
|
| Fasciitis | 1 | 2017 | 20 | 0.140 |
Why?
|
| Algorithms | 2 | 2022 | 1606 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2018 | 133 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 310 | 0.140 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 58 | 0.140 |
Why?
|
| Animals | 12 | 2022 | 34038 | 0.140 |
Why?
|
| Data Curation | 1 | 2016 | 12 | 0.130 |
Why?
|
| Amino Acid Sequence | 5 | 2011 | 2699 | 0.130 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 284 | 0.130 |
Why?
|
| Genetic Variation | 3 | 2018 | 1493 | 0.130 |
Why?
|
| Databases, Genetic | 4 | 2021 | 472 | 0.130 |
Why?
|
| Neurofibroma | 1 | 2016 | 6 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 1699 | 0.130 |
Why?
|
| Tandem Repeat Sequences | 1 | 2015 | 37 | 0.130 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 3872 | 0.130 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2016 | 98 | 0.120 |
Why?
|
| Thyroid Nodule | 1 | 2015 | 20 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 503 | 0.120 |
Why?
|
| Immunoblotting | 1 | 2015 | 310 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 762 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 237 | 0.110 |
Why?
|
| Genome, Human | 2 | 2018 | 1260 | 0.110 |
Why?
|
| Phenotype | 3 | 2019 | 4251 | 0.110 |
Why?
|
| Leukocytosis | 1 | 2014 | 46 | 0.110 |
Why?
|
| Gene Duplication | 1 | 2015 | 361 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 464 | 0.110 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2014 | 67 | 0.110 |
Why?
|
| Karyotyping | 1 | 2014 | 328 | 0.110 |
Why?
|
| Incidental Findings | 1 | 2014 | 125 | 0.110 |
Why?
|
| Genetics, Medical | 1 | 2014 | 118 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 160 | 0.100 |
Why?
|
| Afibrinogenemia | 1 | 2012 | 10 | 0.100 |
Why?
|
| Hematologic Tests | 1 | 2012 | 35 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 416 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3549 | 0.100 |
Why?
|
| 1,4-alpha-Glucan Branching Enzyme | 1 | 2012 | 4 | 0.100 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2012 | 9 | 0.100 |
Why?
|
| Glycogen Storage Disease Type IV | 1 | 2012 | 5 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2012 | 153 | 0.100 |
Why?
|
| Meiosis | 2 | 2009 | 113 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 319 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2011 | 1531 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 332 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 369 | 0.100 |
Why?
|
| Infant, Newborn | 6 | 2020 | 8188 | 0.100 |
Why?
|
| Receptor, trkB | 2 | 2021 | 20 | 0.100 |
Why?
|
| Acrosome | 2 | 2011 | 13 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2019 | 1223 | 0.090 |
Why?
|
| Epithelioid Cells | 1 | 2011 | 11 | 0.090 |
Why?
|
| Nuclear Envelope | 1 | 2011 | 17 | 0.090 |
Why?
|
| Computational Biology | 3 | 2018 | 811 | 0.090 |
Why?
|
| Hemochromatosis | 1 | 2011 | 32 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2011 | 72 | 0.090 |
Why?
|
| Abdominal Neoplasms | 1 | 2011 | 33 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1596 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2011 | 75 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 210 | 0.080 |
Why?
|
| Retroelements | 1 | 2009 | 40 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 469 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2021 | 356 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 657 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 409 | 0.080 |
Why?
|
| Remission Induction | 2 | 2019 | 299 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3266 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1879 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 539 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1264 | 0.070 |
Why?
|
| Chromosome Aberrations | 2 | 2022 | 617 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2009 | 697 | 0.070 |
Why?
|
| Lymphatic Metastasis | 2 | 2020 | 411 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1008 | 0.070 |
Why?
|
| Glycolipids | 1 | 2006 | 32 | 0.070 |
Why?
|
| Oligospermia | 1 | 2006 | 57 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2007 | 211 | 0.070 |
Why?
|
| Cytogenetic Analysis | 2 | 2020 | 79 | 0.070 |
Why?
|
| Contraception | 1 | 2006 | 57 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 282 | 0.060 |
Why?
|
| Ovarian Follicle | 1 | 2007 | 118 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2007 | 178 | 0.060 |
Why?
|
| Terminology as Topic | 2 | 2021 | 222 | 0.060 |
Why?
|
| Software | 2 | 2021 | 677 | 0.060 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2025 | 6 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2006 | 176 | 0.060 |
Why?
|
| Proteins | 2 | 2009 | 1036 | 0.060 |
Why?
|
| Receptors, Cytokine | 1 | 2025 | 68 | 0.060 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 16 | 0.060 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2024 | 20 | 0.060 |
Why?
|
| Biopsy | 2 | 2020 | 1237 | 0.060 |
Why?
|
| Forecasting | 1 | 2006 | 350 | 0.060 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 78 | 0.060 |
Why?
|
| Precision Medicine | 2 | 2018 | 315 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2009 | 716 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1428 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1890 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2024 | 274 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 470 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2004 | 427 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 3328 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 1328 | 0.050 |
Why?
|
| Biological Assay | 1 | 2023 | 102 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1208 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 39 | 0.050 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2022 | 53 | 0.050 |
Why?
|
| Middle Aged | 5 | 2025 | 26588 | 0.050 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2021 | 39 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2021 | 33 | 0.050 |
Why?
|
| Web Browser | 1 | 2021 | 8 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 612 | 0.050 |
Why?
|
| Recurrence | 1 | 2025 | 1421 | 0.050 |
Why?
|
| Salpingo-oophorectomy | 1 | 2020 | 10 | 0.040 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.040 |
Why?
|
| Quinolines | 1 | 2021 | 98 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 748 | 0.040 |
Why?
|
| Imidazoles | 1 | 2021 | 194 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1651 | 0.040 |
Why?
|
| Dactinomycin | 1 | 2019 | 66 | 0.040 |
Why?
|
| Glioma | 1 | 2024 | 489 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1035 | 0.040 |
Why?
|
| Foot Diseases | 1 | 2019 | 22 | 0.040 |
Why?
|
| Base Sequence | 1 | 2004 | 3089 | 0.040 |
Why?
|
| Thoracic Neoplasms | 1 | 2019 | 36 | 0.040 |
Why?
|
| Thigh | 1 | 2019 | 51 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 72 | 0.040 |
Why?
|
| Thoracic Wall | 1 | 2019 | 36 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 1265 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 2041 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 143 | 0.040 |
Why?
|
| Extremities | 1 | 2019 | 82 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2020 | 192 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2018 | 39 | 0.040 |
Why?
|
| Vincristine | 1 | 2019 | 191 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2019 | 177 | 0.040 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Genome | 1 | 2021 | 470 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2018 | 125 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2025 | 834 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2011 | 623 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 132 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2019 | 203 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 779 | 0.040 |
Why?
|
| Access to Information | 1 | 2018 | 40 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 100 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 826 | 0.040 |
Why?
|
| Rats | 1 | 2004 | 3675 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 418 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2018 | 212 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2018 | 231 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 242 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 163 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 237 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2006 | 3430 | 0.030 |
Why?
|
| Everolimus | 1 | 2016 | 47 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 118 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2018 | 439 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 671 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 647 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 154 | 0.030 |
Why?
|
| Texas | 1 | 2024 | 3577 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2015 | 23 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 294 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 237 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 529 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 621 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1032 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2019 | 883 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 223 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 722 | 0.030 |
Why?
|
| Telomerase | 1 | 2015 | 160 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2007 | 4505 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2744 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 204 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 723 | 0.030 |
Why?
|
| Aged | 3 | 2017 | 19533 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 428 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 1015 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2019 | 813 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 525 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1737 | 0.030 |
Why?
|
| Pregnancy | 1 | 2006 | 7174 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2012 | 21 | 0.030 |
Why?
|
| Patched Receptors | 1 | 2011 | 26 | 0.020 |
Why?
|
| Laboratories | 1 | 2012 | 82 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 4342 | 0.020 |
Why?
|
| Patched-1 Receptor | 1 | 2011 | 34 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1696 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 690 | 0.020 |
Why?
|
| Transcriptome | 1 | 2018 | 949 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5132 | 0.020 |
Why?
|
| Autopsy | 1 | 2011 | 111 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 176 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2011 | 127 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 355 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2141 | 0.020 |
Why?
|
| Argonaute Proteins | 1 | 2009 | 24 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 210 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 256 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2497 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 548 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2806 | 0.020 |
Why?
|
| Zona Pellucida | 1 | 2007 | 11 | 0.020 |
Why?
|
| Fertilization | 1 | 2007 | 42 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 660 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 144 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 297 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 406 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 1022 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 355 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 390 | 0.020 |
Why?
|
| Liver | 1 | 2011 | 1733 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 1177 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 555 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 16275 | 0.010 |
Why?
|
| United States | 1 | 2017 | 10861 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 875 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 1561 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 10245 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 6283 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4397 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12288 | 0.010 |
Why?
|